Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Classificação em ações #478
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Preço da ação
$19.63
Valor de mercado
$47.10B
Variação (1 dia)
1.80%
Variação (1 ano)
-7.33%
País
IN
Negociar Sun Pharmaceutical Industries Limited (SUNPHARMA)

Categoria

Receita da Sun Pharmaceutical Industries Limited (SUNPHARMA)
Receita em Dec 2025 TTM: $6.31B
De acordo com os últimos relatórios financeiros da Sun Pharmaceutical Industries Limited, a receita atual da empresa (TTM) é $6.31B. Em 2024, a empresa obteve uma receita de $5.82B um aumento em relação a a receita do ano 2023, que foi de $5.34B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Sun Pharmaceutical Industries Limited de 2004 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $6.31B 2.69%
2025 $6.15B 5.70%
2024 $5.82B 8.91%
2023 $5.34B 4.87%
2022 $5.09B 11.28%
2021 $4.58B 4.98%
2020 $4.36B 4.14%
2019 $4.19B 3.17%
2018 $4.06B -15.97%
2017 $4.83B 13.79%
2016 $4.24B -3.35%
2015 $4.39B 63.63%
2014 $2.68B 29.00%
2013 $2.08B 31.80%
2012 $1.58B 22.91%
2011 $1.28B 47.70%
2010 $869.23M 3.29%
2009 $841.54M 0.33%
2008 $838.79M 70.54%
2007 $491.84M 33.83%
2006 $367.50M 33.92%
2005 $274.42M 20.98%
2004 $226.82M 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$4.43B -29.76%
FR
$24.76B 292.14%
DE
$28.60B 352.97%
JP
$9.47B 49.96%
US
$25.92B 310.58%
GB